Lifemd, Inc.
A telehealth company that lets patients across the US see licensed doctors and nurse practitioners by video for primary care, urgent care, and specialty visits, and can even deliver prescription treatments like GLP-1 weight-loss medications to their door. It began in 1994 under a different name, later became a marketing firm, and took the LifeMD name in 2021 when it turned to virtual care. Fitting its roundabout past, its original name, ImmuDyne, sounded more like a lab equipment maker than a doctor's office.
Sold 75.0K
Granted 22.4K
Granted 337.5K
Granted 22.4K
Sold 15.0K
Granted 200.0K
Granted 22.4K
Granted 22.4K
Granted 75.0K
Granted 22.4K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Alvarez Nicholas PChief Acquisition Officer · 1 transaction | -11% | 605.0K | — | — | 75.0K |
| Strawn John R JrDirector · 1 transaction | +11% | 473.0K | 22.4K | — | — |
| Kavthekar AtulChief Financial Officer · 1 transaction | — | 337.5K | 337.5K | — | — |
| DiTrolio JosephDirector · 1 transaction | +12.5% | 273.4K | 22.4K | — | — |
| Friedeman JessicaChief Marketing Officer · 1 transaction | -6.8% | 205.0K | — | — | 15.0K |
| Pisano Christopher AChief Marketing Officer · 1 transaction | — | 200.0K | 200.0K | — | — |
| Simon RobertoDirector · 1 transaction | +40.9% | 183.2K | 22.4K | — | — |
| Larovere JoanDirector · 1 transaction | +26.4% | 107.0K | 22.4K | — | — |
| Sripad UmeshChief Technology Officer · 1 transaction | — | 75.0K | 75.0K | — | — |
| Macrae Calum ArchibaldDirector · 1 transaction | +135.5% | 38.9K | 22.4K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last year: -90.0K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.